{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:12:12Z","timestamp":1788927132353,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["Broad Agency Announcement (BAA) Contract # HHSF223201810187C"],"award-info":[{"award-number":["Broad Agency Announcement (BAA) Contract # HHSF223201810187C"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s13346-025-02008-2","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:39:34Z","timestamp":1765287574000},"page":"2697-2710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Formulation and characterization of exenatide-loaded PLGA microspheres prepared by coacervation"],"prefix":"10.1007","volume":"16","author":[{"given":"Cameron","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1211-6161","authenticated-orcid":false,"given":"Steven P.","family":"Schwendeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"2008_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0378-5173(98)00101-X","volume":"169","author":"M Igartua","year":"1998","unstructured":"Igartua M, Hern\u00e1ndez RM, Esquisabel A, et al. Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis. Int J Pharm. 1998;169:45\u201354.","journal-title":"Int J Pharm"},{"key":"2008_CR2","unstructured":"Bridges A, Bistas KG, Jacobs TF. Exenatide. In: StatPearls. Treasure Island (FL): StatPearls Publishing. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK518981\/ (2025, accessed 5 February 2025)."},{"key":"2008_CR3","unstructured":"Amylin P. Byetta [package insert]. San Diego, CA, 2005."},{"key":"2008_CR4","unstructured":"Bydureon [package insert]."},{"key":"2008_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijpharm.2006.10.036","volume":"334","author":"S Mao","year":"2007","unstructured":"Mao S, Xu J, Cai C, et al. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm. 2007;334:137\u201348.","journal-title":"Int J Pharm"},{"key":"2008_CR6","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1021\/ac0346712","volume":"75","author":"JN Lee","year":"2003","unstructured":"Lee JN, Park C, Whitesides GM. Solvent compatibility of poly(dimethylsiloxane)-based microfluidic devices. Anal Chem. 2003;75:6544\u201354.","journal-title":"Anal Chem"},{"key":"2008_CR7","unstructured":"Amylin Pharmaceuticals Inc. Poly(lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar. WO2005102293A1. Filed 2004 Apr 15, published 2005 Nov 3."},{"key":"2008_CR8","unstructured":"Dichloromethane. Chemical assessment summary CASRN 75-09-2, Washington D.C.: U.S. Environmental Protection Agency, 2011."},{"key":"2008_CR9","doi-asserted-by":"publisher","unstructured":"Platzer NAJ, editor. Plasticization and Plasticizer Processes. WASHINGTON, D.C.: AMERICAN CHEMICAL SOCIETY. Epub ahead of print 1 January 1965. https:\/\/doi.org\/10.1021\/ba-1965-0048","DOI":"10.1021\/ba-1965-0048"},{"key":"2008_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2337\/dc11-1107","volume":"35","author":"D Russell-Jones","year":"2012","unstructured":"Russell-Jones D, Cuddihy RM, Hanefeld M, et al. Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4). Diabetes Care. 2012;35:252\u20138.","journal-title":"Diabetes Care"},{"key":"2008_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1021\/js970048j","volume":"87","author":"C Thomasin","year":"1998","unstructured":"Thomasin C, Merkle HP, Gander B. Drug microencapsulation by PLA\/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation. J Pharm Sci. 1998;87:269\u201375.","journal-title":"J Pharm Sci"},{"key":"2008_CR12","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.jconrel.2020.10.044","volume":"329","author":"K Park","year":"2021","unstructured":"Park K, Otte A, Sharifi F, et al. Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles. J Controlled Release. 2021;329:1150\u201361.","journal-title":"J Controlled Release"},{"key":"2008_CR13","unstructured":"Q3C - Tables and List Guidance for Industry. U.S Department of Health and Human Services, Food and Drug Administration. Center for Drug Evaluation and Research, June 2017."},{"key":"2008_CR14","doi-asserted-by":"publisher","first-page":"8884","DOI":"10.3390\/ijms22168884","volume":"22","author":"A Butreddy","year":"2021","unstructured":"Butreddy A, Gaddam RP, Kommineni N, et al. PLGA\/PLA-based long-acting injectable depot microspheres in clinical use: production and characterization overview for protein\/peptide delivery. Int J Mol Sci. 2021;22:8884.","journal-title":"Int J Mol Sci"},{"key":"2008_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1081\/PDT-120022155","volume":"8","author":"E Sepulveda","year":"2003","unstructured":"Sepulveda E, Kildsig DO, Ghaly ES. Relationship between internal phase volume and emulsion stability: the cetyl alcohol\/stearyl alcohol system. Pharm Dev Technol. 2003;8:263\u201375.","journal-title":"Pharm Dev Technol"},{"key":"2008_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jconrel.2023.06.016","volume":"361","author":"R Schutzman","year":"2023","unstructured":"Schutzman R, Shi N-Q, Olsen KF, et al. Mechanistic evaluation of the initial burst release of leuprolide from spray-dried PLGA microspheres. J Controlled Release. 2023;361:297\u2013313.","journal-title":"J Controlled Release"},{"key":"2008_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0168-3659(02)00137-2","volume":"82","author":"J Wang","year":"2002","unstructured":"Wang J, Wang BM, Schwendeman SP. Characterization of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres. J Controlled Release. 2002;82:289\u2013307.","journal-title":"J Controlled Release"},{"key":"2008_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/pharmaceutics16030302","volume":"16","author":"H Park","year":"2024","unstructured":"Park H. Exploring the effects of process parameters during W\/O\/W emulsion preparation and supercritical fluid extraction on the protein encapsulation and release properties of PLGA microspheres. Pharmaceutics. 2024;16:302.","journal-title":"Pharmaceutics"},{"key":"2008_CR19","doi-asserted-by":"publisher","first-page":"123213","DOI":"10.1016\/j.ijpharm.2023.123213","volume":"643","author":"A Chandrashekar","year":"2023","unstructured":"Chandrashekar A, Beig A, Wang Y, et al. In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporation. Int J Pharm. 2023;643:123213.","journal-title":"Int J Pharm"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02008-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-02008-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02008-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:32:06Z","timestamp":1783513926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-02008-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2008"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-02008-2","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}